Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02406430
Other study ID # CREUZOT 2013
Secondary ID
Status Completed
Phase N/A
First received March 30, 2015
Last updated March 30, 2015
Start date April 2009

Study information

Verified date March 2015
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority France: Committee for the Protection of Personnes
Study type Observational

Clinical Trial Summary

Retrospective interventional case series study reporting preoperative clinical and anatomical factors associated with visual recovery 1 year after combined cataract and idiopathic epiretinal membrane surgery. Age, duration of symptoms, and preoperative best corrected visual acuity appeared to be reliable prognostic factors. Combining these factors with analysis of the photoreceptors' inner and outer segments junction in spectral-domain optical coherence tomography provides a predictive score to estimate individual chances of good visual recovery


Recruitment information / eligibility

Status Completed
Enrollment 142
Est. completion date
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender Both
Age group 50 Years and older
Eligibility Inclusion Criteria:

- symptomatic idiopathic epiretinal membrane operated on between April 2009 and September 2012 at the university hospital of Dijon, France.

- All patients signed informed consent for the surgical procedure.

Exclusion Criteria:

- Patients were excluded if they presented any cause of secondary epiretinal membrane (including diabetic retinopathy, vein occlusion, ocular inflammation, retinal detachment, or previously vitrectomized eye), high myopia (axial length = 26 mm or spherical equivalent = 6 diopters), severe media opacities with weak SD-OCT signal strengths, or any macular or optic nerve disease. Patients with a follow-up of less than 12 months were excluded and only one eye was included in those with bilateral epiretinal membranes.

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Procedure:
a combined cataract and ERM surgery
All patients underwent a combined cataract and ERM surgery owing to visual impairment or disabling metamorphopsia. A complete ophthalmological examination was performed before and at 1,6, and 12 months after the surgery, including best corrected visual acuity with Snellen charts converted into the logarithm of the minimum angle of resolution, slit-lamp biomicroscopy, indirect fundus, and macular optical coherence tomography

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Outcome

Type Measure Description Time frame Safety issue
Primary Best corrected visual acuity Best corrected visual acuity 1 year after the surgery, and preoperative factors associated with this visual outcome (age, duration of symptoms, initial best corrected visual acuity, and optical coherence tomography findings) 1 year after the surgery No
Secondary To set up a predictive score for a >= 20/20 best corrected visual acuity To set up a predictive score for a >= 20/20 best corrected visual acuity, 1year after a combined cataract and epiretinal membrane surgery 1 year after the surgery No
See also
  Status Clinical Trial Phase
Completed NCT00537992 - Blue-Blocking IOLs in Combined Surgery N/A